AU2001211769A1 - Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof - Google Patents
Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereofInfo
- Publication number
- AU2001211769A1 AU2001211769A1 AU2001211769A AU1176901A AU2001211769A1 AU 2001211769 A1 AU2001211769 A1 AU 2001211769A1 AU 2001211769 A AU2001211769 A AU 2001211769A AU 1176901 A AU1176901 A AU 1176901A AU 2001211769 A1 AU2001211769 A1 AU 2001211769A1
- Authority
- AU
- Australia
- Prior art keywords
- hydrophobic
- heparin conjugates
- preparing method
- present
- conjugates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
- A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0081—Reaction with amino acids, peptides, or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Surgery (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Peptides Or Proteins (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention provides hydrophobic heparin conjugates that are soluble in organic solvents but not in water, a method of preparing them, and a method of using them. Particularly, the present invention provides hydrophobic heparin conjugates that are prepared by covalently binding a polymer to heparin and a hydrophobic agent to the polymer. The hydrophobic heparin conjugates of the present invention maintain a good antithrombogenic effect and are insoluble in water due to their hydrophobicity, so they can be effectively used as coating agents for modifying the surfaces of medical devices.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR0062668 | 2000-10-24 | ||
KR10-2000-0062668A KR100378109B1 (en) | 2000-10-24 | 2000-10-24 | Hydrophobic multicomponant heparin conjugates, a preparing method and a use thereof |
PCT/KR2000/001255 WO2002034312A1 (en) | 2000-10-24 | 2000-11-03 | Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001211769A1 true AU2001211769A1 (en) | 2002-05-06 |
Family
ID=19695171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001211769A Abandoned AU2001211769A1 (en) | 2000-10-24 | 2000-11-03 | Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof |
Country Status (9)
Country | Link |
---|---|
US (1) | US7129224B1 (en) |
EP (1) | EP1333871B1 (en) |
JP (1) | JP3927118B2 (en) |
KR (1) | KR100378109B1 (en) |
CN (1) | CN1209171C (en) |
AT (1) | ATE419022T1 (en) |
AU (1) | AU2001211769A1 (en) |
DE (1) | DE60041283D1 (en) |
WO (1) | WO2002034312A1 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100449889B1 (en) * | 2001-08-30 | 2004-09-22 | 동국제약 주식회사 | Liposome for Containing Anion Polymer and Phospholipid and Manufacturing Method the Same and Application |
US7438925B2 (en) * | 2002-08-26 | 2008-10-21 | Biovention Holdings Ltd. | Drug eluting coatings for medical implants |
US6702850B1 (en) * | 2002-09-30 | 2004-03-09 | Mediplex Corporation Korea | Multi-coated drug-eluting stent for antithrombosis and antirestenosis |
US8293890B2 (en) | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
US7563780B1 (en) * | 2004-06-18 | 2009-07-21 | Advanced Cardiovascular Systems, Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
EP1829567A4 (en) | 2004-12-21 | 2010-07-21 | Univ Shinshu | Medical instrument |
US8883188B2 (en) | 2005-05-04 | 2014-11-11 | Suprapolix B.V. | Modular bioresorbable or biomedical, biologically active supramolecular materials |
EP2087027B1 (en) | 2006-11-20 | 2011-10-05 | SupraPolix B.V. | Supramolecular polymers from low-melting, easily processable building blocks |
US20090281059A1 (en) | 2007-02-21 | 2009-11-12 | Robert Falotico | Coating for a medical device having an anti-thrombotic conjugate |
US20080200421A1 (en) | 2007-02-21 | 2008-08-21 | Zhao Jonathon Z | Coating for a medical device having an anti-thrombotic conjugate |
US8628789B2 (en) | 2007-03-23 | 2014-01-14 | Suprapolix, B.V. | Strong reversible hydrogels |
US9693841B2 (en) | 2007-04-02 | 2017-07-04 | Ension, Inc. | Surface treated staples, sutures and dental floss and methods of manufacturing the same |
US8114465B2 (en) | 2007-04-02 | 2012-02-14 | Ension, Inc. | Process for preparing a substrate coated with a biomolecule |
US8383156B2 (en) | 2007-04-30 | 2013-02-26 | Cordis Corporation | Coating for a medical device having an anti-thrombotic conjugate |
EP2173359A2 (en) * | 2007-06-29 | 2010-04-14 | Mediplex Corp. | Heparin conjugates and methods |
US8088753B2 (en) * | 2007-06-29 | 2012-01-03 | Mediplex Corporation, Korea | Heparin conjugates and methods |
US20090018646A1 (en) | 2007-07-10 | 2009-01-15 | Zhao Jonathon Z | Coating Employing an Anti-Thrombotic Conjugate |
US20100021538A1 (en) * | 2008-02-29 | 2010-01-28 | Youngro Byun | Pharmaceutical compositions containing heparin derivatives |
EP2310376B1 (en) | 2008-07-04 | 2014-11-05 | SupraPolix B.V. | High flow supramolecular compounds |
GB201004101D0 (en) | 2010-03-12 | 2010-04-28 | Carmeda Ab | Immobilised biological entities |
US9446216B2 (en) | 2010-10-14 | 2016-09-20 | Medtronic, Inc. | Cannular device and method of manufacture |
EP2450394B1 (en) | 2010-11-05 | 2017-06-07 | SupraPolix B.V. | A process for the preparation of a supramolecular polymer |
BR112015027122B1 (en) * | 2013-04-26 | 2020-09-29 | Biointeractions Limited | COMPOUND, POLYMERIC COATING, MEDICAL DEVICE, METHOD FOR PRODUCTION OF A POLYMER, AND MIXTURE OF POLYMERS |
ES2829412T3 (en) * | 2013-05-20 | 2021-05-31 | Univ Yale | Antithrombogenic grafts |
US9339770B2 (en) | 2013-11-19 | 2016-05-17 | Applied Membrane Technologies, Inc. | Organosiloxane films for gas separations |
KR101881541B1 (en) * | 2016-07-25 | 2018-07-24 | 가톨릭대학교산학협력단 | Surface treatment method of biodegradable polymer for improvement of osteogenesis or osseointegration |
CN106986955B (en) * | 2017-04-28 | 2019-04-09 | 华南理工大学 | The Azide method of modifying and Azide heparin of a kind of heparin and application |
CN109925536B (en) * | 2017-12-15 | 2021-01-26 | 先健科技(深圳)有限公司 | Absorbable iron-based implantable device |
TWI653993B (en) | 2018-03-20 | 2019-03-21 | 國立臺灣大學 | Vascular substitute |
CN114767325A (en) * | 2022-04-11 | 2022-07-22 | 江苏理工学院 | Artificial blood vessel with microstructure on surface and preparation method thereof |
CN115990297B (en) * | 2023-03-09 | 2023-11-07 | 上海宏普医疗器械有限公司 | Heparin anticoagulation coating based on PTFE material and preparation method thereof |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5357288A (en) * | 1976-11-04 | 1978-05-24 | Nippon Zeon Co Ltd | Anticoagulant medical polymer its preparation and use |
JPS6229532A (en) * | 1985-07-31 | 1987-02-07 | Koken:Kk | Antithrombogenetic medical material and production thereof |
JPH01262869A (en) * | 1988-04-15 | 1989-10-19 | Ube Ind Ltd | Anticoagulant medical treatment implement |
US5270046A (en) * | 1988-09-27 | 1993-12-14 | Ube Industries, Ltd. | Heparin bound anti-thrombotic material |
US5069899A (en) * | 1989-11-02 | 1991-12-03 | Sterilization Technical Services, Inc. | Anti-thrombogenic, anti-microbial compositions containing heparin |
GB9009570D0 (en) * | 1990-04-27 | 1990-06-20 | Biocompatibles Ltd | Antithrombogenic polymers |
DE4217917A1 (en) * | 1992-05-30 | 1993-12-02 | Job Prof Dr Med Harenberg | Heparin-polymer conjugate used to inhibit coagulation in analytical tests - comprises heparin fragments bonded to amino-phenyl substd. polymer |
FR2723847A1 (en) * | 1994-08-29 | 1996-03-01 | Debiopharm Sa | HEPARIN - BASED ANTITHROMBOTIC AND NON - HEMORRHAGIC COMPOSITIONS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC APPLICATIONS. |
JP3341503B2 (en) * | 1994-11-09 | 2002-11-05 | 東レ株式会社 | Antithrombotic medical material and catheter using the same |
US5744457A (en) * | 1995-03-31 | 1998-04-28 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
KR0175975B1 (en) * | 1995-11-03 | 1999-05-15 | 김은영 | Block-copolymers with sulfonic acid for anti-coagulation and medical articles produced therefrom |
FR2752843B1 (en) * | 1996-08-30 | 1998-10-16 | Sod Conseils Rech Applic | CROSSLINKED COPOLYMERS BASED ON POLYCARBOXYLIC POLYMERS AND THEIR USE AS SUPPORTS OF PHARMACEUTICAL COMPOSITIONS |
US6071532A (en) * | 1996-10-15 | 2000-06-06 | Emory University | Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
US6229009B1 (en) * | 1997-08-29 | 2001-05-08 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Polycarboxylic based cross-linked copolymers |
US5955588A (en) * | 1997-12-22 | 1999-09-21 | Innerdyne, Inc. | Non-thrombogenic coating composition and methods for using same |
US6258371B1 (en) * | 1998-04-03 | 2001-07-10 | Medtronic Inc | Method for making biocompatible medical article |
KR100314496B1 (en) | 1998-05-28 | 2001-11-22 | 윤동진 | Non-thrombogenic heparin derivatives, process for preparation and use thereof |
WO1999061481A1 (en) * | 1998-05-28 | 1999-12-02 | Mediplex Corporation, Korea | Amphiphilic polysaccharide derivatives |
JP4358331B2 (en) * | 1998-11-12 | 2009-11-04 | Junken Medical株式会社 | Anti-blood coagulation material with excellent transparency and medical device coated with anti-coagulation material |
US6702850B1 (en) * | 2002-09-30 | 2004-03-09 | Mediplex Corporation Korea | Multi-coated drug-eluting stent for antithrombosis and antirestenosis |
-
2000
- 2000-10-24 KR KR10-2000-0062668A patent/KR100378109B1/en not_active IP Right Cessation
- 2000-11-03 DE DE60041283T patent/DE60041283D1/en not_active Expired - Fee Related
- 2000-11-03 AT AT00973237T patent/ATE419022T1/en not_active IP Right Cessation
- 2000-11-03 EP EP00973237A patent/EP1333871B1/en not_active Expired - Lifetime
- 2000-11-03 WO PCT/KR2000/001255 patent/WO2002034312A1/en active Application Filing
- 2000-11-03 JP JP2002537363A patent/JP3927118B2/en not_active Expired - Fee Related
- 2000-11-03 CN CNB008199868A patent/CN1209171C/en not_active Expired - Fee Related
- 2000-11-03 AU AU2001211769A patent/AU2001211769A1/en not_active Abandoned
- 2000-11-03 US US10/333,641 patent/US7129224B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR20020031894A (en) | 2002-05-03 |
EP1333871B1 (en) | 2008-12-31 |
EP1333871A4 (en) | 2004-07-07 |
CN1209171C (en) | 2005-07-06 |
CN1455687A (en) | 2003-11-12 |
EP1333871A1 (en) | 2003-08-13 |
JP3927118B2 (en) | 2007-06-06 |
ATE419022T1 (en) | 2009-01-15 |
JP2004512397A (en) | 2004-04-22 |
KR100378109B1 (en) | 2003-03-29 |
US7129224B1 (en) | 2006-10-31 |
WO2002034312A1 (en) | 2002-05-02 |
DE60041283D1 (en) | 2009-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001211769A1 (en) | Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof | |
WO2000040203A3 (en) | Polymeric delivery agents and delivery agent compounds | |
NO20061840L (en) | Drug coatings that provide high drug additives and methods for providing the same | |
NO20071944L (en) | Hydrolysis Stable Investment Agent Composition | |
WO2002005800A8 (en) | Compositions for sustained release of analgesic agents, and methods of making and using the same | |
ATE399827T1 (en) | ABSORBENT AND SLIDING COATING AGENT AND PRODUCTS COATED THEREFROM | |
WO2002080993A3 (en) | Coating for medical devices | |
MX2007010771A (en) | Angiogenic heparin binding peptide amphiphiles. | |
WO2001017614A3 (en) | Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents | |
ID27310A (en) | PART OF POLYMER INTERPENETRATION NETWORK | |
WO2004021968A3 (en) | Solution for ungual application | |
EP1478406A4 (en) | Compositions for delivery of therapeutics and other materials, and methods of making and using the same | |
AR019608A1 (en) | ABSORBENT POLYMER, PROCEDURE FOR PREPARATION, AND APPLICATION | |
IN2001KO00412A (en) | ||
WO2007064968A3 (en) | Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate | |
DE69826684D1 (en) | COVALENT-TIED N, O-CARBOXYMETHYLCHITOSAN AND ITS USE | |
WO2001076645A3 (en) | Targeted agents useful for diagnostic and therapeutic applications | |
WO2004022839A3 (en) | Textile rinsing formulation | |
AU2831900A (en) | Stereocomplex hydrogels | |
AU2001235783A1 (en) | Therapeutic compositions for pulmonary delivery | |
GB2364314B (en) | Organic anti-reflective coating polymer,anti-reflective coating composition comprising the same and preparation methods thereof | |
BR0012722B1 (en) | coating color composition, coated cellulose article, and water soluble polymer for use in a coating color composition. | |
NO20030073D0 (en) | Drug delivery system for drugs that are not water soluble | |
WO2003007914A3 (en) | Biocompatible polymer containing composition for treatment of prostate cancers | |
GB2364306B (en) | Organic anti-reflective coating polymer,anti-reflective coating composition comprising the same and method of preparation thereof |